Vasopressin

(Vasostrict®)

Vasostrict®

Drug updated on 10/23/2023

Dosage FormInjection (intravenous: 20 units/mL, 200 units/10 mL) Injection (intravenous: (20 units/100 mL (0.2 units/mL), 40 units/100 mL (0.4 units/mL), and 60 units/100 mL (0.6 units/mL))
Drug ClassAntidiuretic hormone
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Product Monograph / Prescribing Information

Document TitleYearSource
Vasostrict (vasopressin) Prescribing Information.2021Par Pharmaceutical Chestnut Ridge, NY

Systematic Reviews / Meta-Analyses